322 related articles for article (PubMed ID: 18266290)
1. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.
Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S
Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-HIV evaluation of the novel 2-(m-chlorobenzyl)-4-substituted-7-methyl-1, 1, 3-trioxo-pyrazolo[4, 5-e] [1, 2, 4]thiadiazines.
Yan RZ; Liu XY; Xu WF; Pannecouque C; Witvrouw M; De Clercq E
Arch Pharm Res; 2006 Nov; 29(11):957-62. PubMed ID: 17146963
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs).
Lin Y; Liu X; Yan R; Li J; Pannecouque C; Witvrouw M; De Clercq E
Bioorg Med Chem; 2008 Jan; 16(1):157-63. PubMed ID: 17964796
[TBL] [Abstract][Full Text] [Related]
4. In-vitro anti-HIV and antitumor activity of new 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and thiadiazine analogues.
Al-Soud YA; Al-Masoudi NA; Loddo R; La Colla P
Arch Pharm (Weinheim); 2008 Jun; 341(6):365-9. PubMed ID: 18493972
[TBL] [Abstract][Full Text] [Related]
5. Novel potential agents for human cytomegalovirus infection: synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides.
Martinez A; Esteban AI; Castro A; Gil C; Conde S; Andrei G; Snoeck R; Balzarini J; De Clercq E
J Med Chem; 1999 Apr; 42(7):1145-50. PubMed ID: 10197958
[TBL] [Abstract][Full Text] [Related]
6. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-HIV activity of novel 3-substituted phenyl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
Ali MA; Ismail R; Choon TS; Yoon YK; Wei AC; Pandian S; Samy JG; De Clercq E; Pannecouque C
Acta Pol Pharm; 2011; 68(3):343-8. PubMed ID: 21648188
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-HIV-1 activity of a novel series of 1,4,2-benzodithiazine-dioxides.
Brzozowski Z; Saczewski F; Neamati N
Bioorg Med Chem Lett; 2006 Oct; 16(20):5298-302. PubMed ID: 16908143
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors.
Arranz ME; Díaz JA; Ingate ST; Witvrouw M; Pannecouque C; Balzarini J; De Clercq E; Vega S
Bioorg Med Chem; 1999 Dec; 7(12):2811-22. PubMed ID: 10658585
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-HIV activity of different novel nonclassical nucleosides.
Elgemeie GE; Mansour OA; Metwally NH
Nucleosides Nucleotides; 1999 Jan; 18(1):113-23. PubMed ID: 10048227
[TBL] [Abstract][Full Text] [Related]
11. 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.
Zhan P; Liu X; Fang Z; Pannecouque C; De Clercq E
Bioorg Med Chem; 2009 Sep; 17(17):6374-9. PubMed ID: 19647440
[TBL] [Abstract][Full Text] [Related]
12. Novel 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replication.
Arranz E; Díaz JA; Ingate ST; Witvrouw M; Pannecouque C; Balzarini J; De Clercq E; Vega S
J Med Chem; 1998 Oct; 41(21):4109-17. PubMed ID: 9767646
[TBL] [Abstract][Full Text] [Related]
13. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
[TBL] [Abstract][Full Text] [Related]
14. Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues.
Sun GF; Kuang YY; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Arch Pharm (Weinheim); 2005 Oct; 338(10):457-61. PubMed ID: 16211654
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.
Mahajan DH; Pannecouque C; De Clercq E; Chikhalia KH
Arch Pharm (Weinheim); 2009 May; 342(5):281-90. PubMed ID: 19415671
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound.
Tomassi C; Nguyen VN; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Soriano E; Postel D
Bioorg Med Chem Lett; 2008 Apr; 18(7):2277-81. PubMed ID: 18353641
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-HIV-1 activities of novel podophyllotoxin derivatives.
Chen SW; Wang YH; Jin Y; Tian X; Zheng YT; Luo DQ; Tu YQ
Bioorg Med Chem Lett; 2007 Apr; 17(7):2091-5. PubMed ID: 17317161
[TBL] [Abstract][Full Text] [Related]
18. Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
Al-Soud YA; Al-Masoudi NA; Hassan HG; De Clercq E; Pannecouque C
Acta Pharm; 2007 Dec; 57(4):379-93. PubMed ID: 18165184
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel MKC-442 analogues with potent activities against HIV-1.
El-Brollosy NR; Pedersen EB; Nielsen C
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):236-41. PubMed ID: 12916058
[TBL] [Abstract][Full Text] [Related]
20. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents.
Sun IC; Wang HK; Kashiwada Y; Shen JK; Cosentino LM; Chen CH; Yang LM; Lee KH
J Med Chem; 1998 Nov; 41(23):4648-57. PubMed ID: 9804704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]